{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:13:59Z","timestamp":1769148839976,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T00:00:00Z","timestamp":1456531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11060-016-2073-5","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T09:50:02Z","timestamp":1456566602000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids"],"prefix":"10.1007","volume":"128","author":[{"given":"Eduard H.","family":"Panosyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L.","family":"Lasky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Hai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley F.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy F.","family":"Cloughesy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Leia","family":"Nghiemphu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,27]]},"reference":[{"issue":"7","key":"2073_CR1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.18632\/oncotarget.190","volume":"1","author":"A Wolf","year":"2010","unstructured":"Wolf A, Agnihotri S, Guha A (2010) Targeting metabolic remodeling in glioblastoma multiforme. Oncotarget 1(7):567","journal-title":"Oncotarget"},{"key":"2073_CR2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/neuonc\/nor054","volume":"13","author":"C Foug\u00e8re la","year":"2011","unstructured":"la Foug\u00e8re C, Suchorska B, Bartenstein P, Kreth F-W, Tonn J-C (2011) Molecular imaging of gliomas with PET: opportunities and limitations. Neuro-Oncology 13:806\u2013819. doi: 10.1093\/neuonc\/nor054","journal-title":"Neuro-Oncology"},{"key":"2073_CR3","first-page":"55","volume":"105","author":"K-J Langen","year":"2008","unstructured":"Langen K-J, Tatsch K, Grosu A-L, Jacobs AH, Weckesser M, Sabri O (2008) Diagnostics of cerebral gliomas with radiolabeled amino acids. Dtsch Arztebl Int 105:55\u201361. doi: 10.3238\/arztebl.2008.0055","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"2073_CR4","first-page":"70","volume":"59","author":"N Galldiks","year":"2014","unstructured":"Galldiks N, Langen K (2014) Applications of PET imaging of neurological tumors with radiolabeled amino acids. Q J Nucl Med Mol Imaging 59(1):70\u201382","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2073_CR5","first-page":"4082","volume":"45","author":"G Dranoff","year":"1985","unstructured":"Dranoff G, Elion GB, Friedman HS, Bigner DD (1985) Combination chemotherapy in vitro exploiting glutamine metabolism of human glioma and medulloblastoma. Cancer Res 45:4082\u20134086","journal-title":"Cancer Res"},{"key":"2073_CR6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1158\/1541-7786.MCR-13-0576","volume":"12","author":"EH Panosyan","year":"2014","unstructured":"Panosyan EH, Wang Y, Xia P, Lee W-NP, Pak Y, Laks DR, Lin HJ, Moore TB, Cloughesy TF, Kornblum HI, Lasky JL (2014) Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors. Mol Cancer Res 12:694\u2013702. doi: 10.1158\/1541-7786.mcr-13-0576","journal-title":"Mol Cancer Res"},{"key":"2073_CR7","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1158\/0008-5472.CAN-10-1666","volume":"70","author":"MJ Seltzer","year":"2010","unstructured":"Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, Tsukamoto T, Rojas CJ, Slusher BS, Rabinowitz JD, Dang CV, Riggins GJ (2010) Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res 70:8981\u20138987. doi: 10.1158\/0008-5472.can-10-1666","journal-title":"Cancer Res"},{"key":"2073_CR8","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.1991.9.8.1476","volume":"9","author":"SA Taylor","year":"1991","unstructured":"Taylor SA, Crowley J, Pollock TW, Eyre HJ, Jaeckle C, Hynes HE, Stephens RL (1991) Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group trial. J Clin Oncol 9:1476\u20131479","journal-title":"J Clin Oncol"},{"key":"2073_CR9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1200\/JCO.1999.17.3.984","volume":"17","author":"SM Chang","year":"1999","unstructured":"Chang SM, Kuhn JG, Robins HI, Schold SC, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Schiff D, Gilbert M, Rankin C, Prados MD (1999) Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American brain tumor consortium report. J Clin Oncol 17:984","journal-title":"J Clin Oncol"},{"key":"2073_CR10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.3217","volume":"19","author":"M Tonjes","year":"2013","unstructured":"Tonjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AHC, Karra D, Piro RM, Felsberg J, Addington A, Lemke D, Weibrecht I, Hovestadt V, Rolli CG, Campos B, Turcan S, Sturm D, Witt H, Chan TA, Herold-Mende C, Kemkemer R, Konig R, Schmidt K, Hull W-E, Pfister SM, Jugold M, Hutson SM, Plass C, Okun JG, Reifenberger G, Lichter P, Radlwimmer B (2013) BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat Med 19:901\u2013908. doi: 10.1038\/nm.3217.html#supplementary-information .","journal-title":"Nat Med"},{"issue":"8","key":"2073_CR11","first-page":"E789","volume":"304","author":"MN Balasubramanian","year":"2013","unstructured":"Balasubramanian MN, Butterworth EA, Kilberg MS (2013) Asparagine synthetase: regulation by cell stress and involvement in tumor biology 304(8):E789\u2013E799","journal-title":"Asparagine synthetase: regulation by cell stress and involvement in tumor biology"},{"key":"2073_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB (2010) Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 35:427\u2013433. doi: 10.1016\/j.tibs.2010.05.003","journal-title":"Trends Biochem Sci"},{"key":"2073_CR13","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/2014.9.FOCUS14505","volume":"37","author":"S Agnihotri","year":"2014","unstructured":"Agnihotri S, Aldape KD, Zadeh G (2014) Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma. Neurosurg Focus 37:E13. doi: 10.3171\/2014.9.focus14505","journal-title":"Neurosurg Focus"},{"key":"2073_CR14","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.1019393108","volume":"108","author":"ZJ Reitman","year":"2011","unstructured":"Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, Kinzler KW, He Y, Bigner DD, Vogelstein B, Yan H (2011) Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci 108:3270\u20133275. doi: 10.1073\/pnas.1019393108","journal-title":"Proc Natl Acad Sci"},{"key":"2073_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/bpa.12022","volume":"23","author":"S Venneti","year":"2013","unstructured":"Venneti S, Thompson CB (2013) Metabolic modulation of epigenetics in gliomas. Brain Pathol 23:217\u2013221. doi: 10.1111\/bpa.12022","journal-title":"Brain Pathol"},{"key":"2073_CR16","first-page":"157","volume-title":"Amino acids synthesized from glutamate: glutamine, proline, ornithine, citrulline and arginine. Amino acid metabolism","author":"DA Bender","year":"2012","unstructured":"Bender DA (2012) Amino acids synthesized from glutamate: glutamine, proline, ornithine, citrulline and arginine. Amino acid metabolism. Wiley, New York, pp 157\u2013223"},{"key":"2073_CR17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2014.08.018","volume":"56","author":"J Zhang","year":"2014","unstructured":"Zhang J, Fan J, Venneti S, Cross Justin R, Takagi T, Bhinder B, Djaballah H, Kanai M, Cheng Emily H, Judkins Alexander R, Pawel B, Baggs J, Cherry S, Rabinowitz Joshua D, Thompson Craig B (2014) Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Mol Cell 56:205\u2013218. doi: 10.1016\/j.molcel.2014.08.018","journal-title":"Mol Cell"},{"key":"2073_CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1755-8794-1-52","volume":"1","author":"Y Lee","year":"2008","unstructured":"Lee Y, Scheck A, Cloughesy T, Lai A, Dong J, Farooqi H, Liau L, Horvath S, Mischel P, Nelson S (2008) Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. BMC Med Genom 1:52","journal-title":"BMC Med Genom"},{"key":"2073_CR19","unstructured":"http:\/\/probesetanalyzer.com\/"},{"key":"2073_CR20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-013-1135-1","volume":"113","author":"S Mareninov","year":"2013","unstructured":"Mareninov S, De Jesus J, Sanchez D, Kay A, Wilson R, Babic I, Chen W, Telesca D, Lou J, Mirsadraei L, Gardner T, Khanlou N, Vinters H, Shafa B, Lai A, Liau L, Mischel P, Cloughesy T, Yong W (2013) Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1\u00a0year of room temperature storage. J Neurooncol 113:365\u2013373. doi: 10.1007\/s11060-013-1135-1","journal-title":"J Neurooncol"},{"key":"2073_CR21","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/djs357","volume":"104","author":"AP Chou","year":"2012","unstructured":"Chou AP, Chowdhury R, Li S, Chen W, Kim AJ, Piccioni DE, Selfridge JM, Mody RR, Chang S, Lalezari S, Lin J, Sanchez DE, Wilson RW, Garrett MC, Harry B, Mottahedeh J, Nghiemphu PL, Kornblum HI, Mischel PS, Prins RM, Yong WH, Cloughesy T, Nelson SF, Liau LM, Lai A (2012) Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas. J Natl Cancer Inst 104:1458\u20131469. doi: 10.1093\/jnci\/djs357","journal-title":"J Natl Cancer Inst"},{"key":"2073_CR22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/neuonc\/nos273","volume":"15","author":"M Weller","year":"2013","unstructured":"Weller M, Cloughesy T, Perry JR, Wick W (2013) Standards of care for treatment of recurrent glioblastoma\u2014are we there yet? Neuro-Oncology 15:4\u201327. doi: 10.1093\/neuonc\/nos273","journal-title":"Neuro-Oncology"},{"key":"2073_CR23","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1158\/0008-5472.CAN-11-1245","volume":"71","author":"M Squatrito","year":"2011","unstructured":"Squatrito M, Holland EC (2011) DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance. Cancer Res 71:5945\u20135949. doi: 10.1158\/0008-5472.can-11-1245","journal-title":"Cancer Res"},{"key":"2073_CR24","first-page":"CD008218","volume":"9","author":"M Khasraw","year":"2014","unstructured":"Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N (2014) Antiangiogenic therapy for high-grade glioma. Cochrane Database Syst Rev 9:CD008218. doi: 10.1002\/14651858.CD008218.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"2073_CR25","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/cancers6041953","volume":"6","author":"M Patel","year":"2014","unstructured":"Patel M, Kim J, Ruzevick J, Li G, Lim M (2014) The future of glioblastoma therapy: synergism of standard of care and immunotherapy. Cancers 6:1953\u20131985","journal-title":"Cancers"},{"key":"2073_CR26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S1807-59322011001300005","volume":"66","author":"SKN Marie","year":"2011","unstructured":"Marie SKN, Shinjo SMO (2011) Metabolism and brain cancer. Clinics 66:33\u201343","journal-title":"Clinics"},{"key":"2073_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","volume":"11","author":"SE Weinberg","year":"2015","unstructured":"Weinberg SE, Chandel NS (2015) Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol 11:9\u201315. doi: 10.1038\/nchembio.1712","journal-title":"Nat Chem Biol"},{"key":"2073_CR28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-200544040-00003","volume":"44","author":"VI Avramis","year":"2005","unstructured":"Avramis VI, Panosyan EH (2005) Pharmacokinetic\/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future. Clin Pharmacokinet 44:367\u2013393","journal-title":"Clin Pharmacokinet"},{"key":"2073_CR29","doi-asserted-by":"crossref","first-page":"e115842","DOI":"10.1371\/journal.pone.0115842","volume":"9","author":"V Stathias","year":"2014","unstructured":"Stathias V, Pastori C, Griffin TZ, Komotar R, Clarke J, Zhang M, Ayad NG (2014) Identifying glioblastoma gene networks based on hypergeometric test analysis. PLoS ONE 9:e115842. doi: 10.1371\/journal.pone.0115842","journal-title":"PLoS ONE"},{"key":"2073_CR30","first-page":"CD007415","volume":"4","author":"MG Hart","year":"2013","unstructured":"Hart MG, Garside R, Rogers G, Stein K, Grant R (2013) Temozolomide for high grade glioma. Cochrane Database Syst Rev 4:CD007415. doi: 10.1002\/14651858.CD007415.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2073_CR31","first-page":"255","volume":"11","author":"S-H Wu","year":"2014","unstructured":"Wu S-H, Bi J-F, Cloughesy T, Cavenee WK, Mischel PS (2014) Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance. Cancer Biol Med 11:255\u2013263. doi: 10.7497\/j.issn.2095-3941.2014.04.004","journal-title":"Cancer Biol Med"},{"key":"2073_CR32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1517\/13543784.2013.806484","volume":"22","author":"Q Gao","year":"2013","unstructured":"Gao Q, Lei T, Ye F (2013) Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma. Expert Opin Investig Drugs 22:1023\u20131040. doi: 10.1517\/13543784.2013.806484","journal-title":"Expert Opin Investig Drugs"},{"key":"2073_CR33","unstructured":"R2: Genomics Analysis and Visualization Platform ( http:\/\/r2.amc.nl ). http:\/\/hgserver1.amc.nl\/cgi-bin\/r2\/main.cgi"},{"key":"2073_CR34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","volume":"13","author":"MI Gross","year":"2014","unstructured":"Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J, MacKinnon AL, Parlati F, Rodriguez MLM, Shwonek PJ, Sjogren EB, Stanton TF, Wang T, Yang J, Zhao F, Bennett MK (2014) Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther 13:890\u2013901. doi: 10.1158\/1535-7163.mct-13-0870","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2073-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2073-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2073-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:22:58Z","timestamp":1559362978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2073-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2073"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2073-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,27]]}}}